By evaluating the mRNA expression of TJP1, TJP2, and TJP3 in 40 different cancer cell lines, we found that TJP1, TJP2, and TJP3 were upregulated in 29, 40, and 12 different cancer cell types, respectively (Fig. 1). Here, TJP2 is linked to cancer.